MALVERN, PA — Ocugen, Inc. (Nasdaq: OCGN) reported fourth quarter and full-year 2025 financial results and provided updates ...

GelMEDIX Inc., a biotechnology company developing regenerative therapies to restore vision, and Catalent, Inc., the leader in enabling the development and supply of better treatments for patients ...

Vertex Pharmaceuticals Incorporated ( VRTX) Barclays 28th Annual Global Healthcare Conference March 11, 2026 11:30 AM EDT ...

GelMEDIX Inc., a biotechnology company developing regenerative therapies to restore vision, and Catalent Inc., a global contract development and manufacturing organization (CDMO), have partnered to ...

CRF awards four global grants to advance CHM research toward new clinical trial endpoints and therapeutic approaches—driving progress toward treatments.

Toronto, ON - March 6, 2026 - Cloudcure, a specialized health platform dedicated to improving metabolic health through ...

4D Molecular Therapeutics, Inc. ( FDMT) TD Cowen 46th Annual Health Care Conference March 3, 2026 10:30 AM EST ...

ADC Therapeutics recently reported its fourth quarter and full-year 2025 financial results, providing an update on the company's achievements in 2025 and its excitement for the future. The company has ...

Drugmakers must focus on developing new antibiotics to fight hospital “superbugs” including meningitis and other infections that can resist last-line treatments, the World Health Organization (WHO) ...

Brandon-based functional neurology clinic introduces a structured fly-in rehabilitation program for post-concussion ...

Diabetes affects hundreds of millions of people worldwide, and one of its most feared complications is vision loss. High ...